Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-28

FDA Approved: ARIPIPRAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for aripiprazole submitted by Alembic Pharmaceuticals Inc., authorizing a modification to the product's approved lab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)

Snippet

SUPPL AP for ARIPIPRAZOLE (ARIPIPRAZOLE)